Pharmaceutical composition for removing chloasma

A technology for removing chloasma and a composition, which is applied in the directions of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of difficult symptomatic treatment, repeated raw materials, etc., and achieve the effects of obvious effect, good inhibitory effect, and good synergistic elimination effect.

Inactive Publication Date: 2014-11-26
ZUNYI LUSHENG HEALTH SOURCE & TECH DEV
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, my country's State Food and Drug Administration has approved 246 varieties with the function of removing chloasma. The formula is simple, the raw materials are repeated, and it is difficult to treat the symptoms. It is difficult to meet the huge demand of the population in my country.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for removing chloasma
  • Pharmaceutical composition for removing chloasma
  • Pharmaceutical composition for removing chloasma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0137] refer to Figure 1 to Figure 5 , Preferred Embodiment 1 of the present invention provides a pharmaceutical composition for removing chloasma, which contains the following raw material components in percentage by weight: Salvia miltiorrhiza extract 20-60%, Angelica sinensis extract 20-40%, Green tea extract tea polyphenols 10-30%, rose extract 10-35%, grape seed extract 5-30%.

[0138] The preparation method of the salvia miltiorrhiza extract: wash and dry the medicinal material salvia miltiorrhiza, crush it into small pieces, weigh the crushed salvia miltiorrhiza, put it into an extraction tank, add ethanol with a content of 85%, and the amount of ethanol added is the weight of the salvia miltiorrhiza 8-10 times (W / W), and extracted three times with ethanol under reflux. During the first reflux extraction, start timing from heating to boiling 96°C, and reflux extraction for 2 hours; after the first reflux extraction is completed, the second operation is the same as abo...

Embodiment 2

[0144] Formula (per 1000 capsules): 130g of Danshen extract, 135g of angelica extract, 50g of tea polyphenols, 80g of rose flower extract, 90g of grape seed extract, 10g of dextrin, and 5g of magnesium stearate. The raw materials are sieved, mixed evenly, and then supplementary materials magnesium stearate and dextrin are added appropriately, mixed evenly, poured into capsules to prepare capsules.

Embodiment 3

[0146] Formula (calculated per 1000 tablets): 128g of Danshen extract, 122g of angelica extract, 60g of tea polyphenols, 90g of rose flower extract, 80g of grape seed extract, 15g of dextrin, and 5g of magnesium stearate. The raw materials are sieved, mixed evenly, and then supplementary materials magnesium stearate and dextrin are added, mixed evenly, and compressed into tablets to obtain tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention aims at providing a pharmaceutical composition with a chloasma removing function. In order to achieve the purpose, the adopted technical scheme is as follows: the pharmaceutical composition with the chloasma removing function contains the following raw material components in percentage by weight: 20-60% of salviae miltiorrhizae extract, 20-40% of angelica extract, 10-30% of green tea extract tea polyphenol, 10-35% of rose extract and 5-30% of grape seed extract. Compared with the existing other preparations, the pharmaceutical composition is a pure traditional Chinese medicine preparation containing no toxic medicinal material, different extraction preparation production processes and key technologies are adopted according to the characteristics of the medicinal materials and the content and stability of the extracted active ingredients are guaranteed; the pharmaceutical composition has the characteristics of obvious curative effect, low cost, high curative effect, quickness in effect taking, no toxic and side effects and the like.

Description

Technical field [0001] The present invention involves the field of traditional Chinese medicine, especially a drug composition with freckle and health care for melasma. Background technique [0002] Lloabichalite, Chinese medicine is called "liver spots" and "黧 black spots". It is manifested as the facial facial facial lighter browning skin pigmentation changes. Its disease damage is yellow -brown or brown spots.The face can sometimes be fused with each other, like a butterfly, which can be worse after sun exposure.It is more common in women above middle age. Patients are generally accompanied by corresponding endocrine disorders, such as insomnia and irritability.The melasma is now outside, and the reason is that the inside is the signal of qi, blood, yin and yang disorders in the body, and can reflect the prosperity of the viscera function.The cause of melasma is mainly caused by women's endocrine disorders, high mental stress, various diseases (liver and kidney dysfunction, gy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/87A61P17/00A61P17/18
Inventor 孙亚丽
Owner ZUNYI LUSHENG HEALTH SOURCE & TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap